Clinical inertia
These meetings are intended for UK Healthcare Professionals and have been developed in accordance with the ABPI Code of Practice.
PM Healthcare events are Quality Assured by the University of Bradford
| Satellite | Clinical inertia | |||
| Speakers | Sally James, Divisional Lead Pharmacist for Unscheduled Care, Royal Liverpool and Broadgreen University Hospital | |||
| Satellite Description | ||||
|
Achieving tight glycaemic control early on in people with type 2 diabetes is known to have beneficial effects on mortality, macrovascular and microvascular complications. National guidelines for type 2 diabetes recommend individualised targets for glycaemic control, but many people are not adequately reaching these targets. One major reason for not achieving these targets is ‘clinical inertia’, defined as ‘failure of healthcare providers to initiate or intensify therapy when indicated’. The session will look at the reasons for clinical inertia in the management of type 2 diabetes and potential strategies for overcoming it. Level: Advanced
Medical Division and Diabetes specialist pharmacist at the Royal Liverpool University Hospitals with many years of hospital experience. An active member of the UKCPA diabetes and endocrine group and I have worked with NICE on preventing type 2 diabetes guidance and CPPE on type 2 diabetes focal points and other projects. Have a passion for prevention and optimising patient care for people with type 2 diabetes . | ||||
